Syon Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

Syon Capital’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$518K	Buy	964 +1	+0.1%	+$512	0.02%	618
2026 Q1	$504K	Sell	963 -2	-0.2%	-$956	0.03%	550
2025 Q4	$562K	Hold	965	–	–	0.03%	518
2025 Q3	$443K	Buy	965 +2	+0.2%	+$746	0.02%	535
2025 Q2	$291K	Sell	963 -143	-13%	-$42.6K	0.02%	560
2025 Q1	$366K	Buy	1,106 +92	+9%	+$30.2K	0.03%	371
2024 Q4	$313K	Buy	+1,014	New	+$285K	0.03%	388

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Syon Capital's MDGL Position: Q2 2026 in Review

Syon Capital increased its Madrigal Pharmaceuticals (MDGL) stake by 0.1% in Q2 2026, buying an estimated $512 and bringing the position to 964 shares worth $518K. The position accounts for 0.02% of the portfolio, ranked #618.

Syon Capital first reported a position in MDGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $562K in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Syon Capital held 964 shares of Madrigal Pharmaceuticals worth $518K as of Q2 2026.
Syon Capital bought 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
Madrigal Pharmaceuticals made up 0.02% of Syon Capital's portfolio in Q2 2026, its #618 holding.
Syon Capital first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Syon Capital's Madrigal Pharmaceuticals position peaked at $562K in Q4 2025.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.